World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roth, 2018, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1736, 10.1016/S0140-6736(18)32203-7
2013
Cooney, 2009, Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians, J Am Coll Cardiol, 54, 1209, 10.1016/j.jacc.2009.07.020
Karmali, 2017, Risk scoring for the primary prevention of cardiovascular disease, Cochrane Database Syst Rev, 3
Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3
D'Agostino, 2008, General cardiovascular risk profile for use in primary care: the Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579
2016, Statin use for the primary prevention of cardiovascular disease in adults: Us Preventive Services task force recommendation statement, JAMA, 316, 1997, 10.1001/jama.2016.15450
Pylypchuk, 2018, Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study, Lancet, 391, 1897, 10.1016/S0140-6736(18)30664-0
Hippisley-Cox, 2017, Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study, BMJ, 357
D'Agostino, 2013, Cardiovascular disease risk assessment: insights from Framingham, Glob Heart, 8, 11, 10.1016/j.gheart.2013.01.001
Ueda, 2017, Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys, Lancet Diabetes Endocrinol, 5, 196, 10.1016/S2213-8587(17)30015-3
Assmann, 2007, Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study, Eur J Clin Invest, 37, 925, 10.1111/j.1365-2362.2007.01888.x
Cooney, 2010, Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?, Circulation, 122, 300, 10.1161/CIRCULATIONAHA.109.852756
Mortensen, 2018, Comparison of five major guidelines for statin use in primary prevention in a contemporary general population, Ann Intern Med, 168, 85, 10.7326/M17-0681
van Houwelingen, 2000, Validation, calibration, revision and combination of prognostic survival models, Stat Med, 19, 3401, 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2
Farzadfar, 2011, National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants, Lancet, 377, 578, 10.1016/S0140-6736(10)62038-7
James, 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7
2017, Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults, Lancet, 390, 2627, 10.1016/S0140-6736(17)32129-3
2017, Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants, Lancet, 389, 37, 10.1016/S0140-6736(16)31919-5
2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8
Gaziano, 2016, Comparison of nonblood-based and blood-based total CV risk scores in global populations, Glob Heart, 11, 37, 10.1016/j.gheart.2015.12.003
Danesh, 2007, The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1·1 million participants in 104 prospective studies of cardiovascular diseases, Eur J Epidemiol, 22, 839, 10.1007/s10654-007-9165-7
Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, JAMA, 314, 52, 10.1001/jama.2015.7008
Murray, 2012, GBD 2010: design, definitions, and metrics, Lancet, 380, 2063, 10.1016/S0140-6736(12)61899-6
2017, Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1345, 10.1016/S0140-6736(17)32366-8
Woodward, 2012, The Asia Pacific Cohort Studies Collaboration: a decade of achievements, Glob Heart, 7, 343, 10.1016/j.gheart.2012.10.001
Wang, 2015, Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi–Provincial Cohort Study, Eur J Prev Cardiol, 22, 380, 10.1177/2047487313516563
Suebsamran, 2016, Association between alcohol consumption and pre-diabetes among 383,442 Thai population aged 15 years and older in Ubon Ratchathani: analytical cross-sectional study, J Med Assoc Thai, 99, S35
Khalili, 2012, Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study, Am J Epidemiol, 176, 177, 10.1093/aje/kws204
Sudlow, 2015, UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age, PLoS Med, 12, 10.1371/journal.pmed.1001779
Di Angelantonio, 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619
Sarwar, 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9
Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8
Thompson, 2010, Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies, Int J Epidemiol, 39, 1345, 10.1093/ije/dyq063
Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
Royston, 2004, Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer, Stat Med, 23, 907, 10.1002/sim.1691
Parzen, 1999, A global goodness-of-fit statistic for Cox regression models, Biometrics, 55, 580, 10.1111/j.0006-341X.1999.00580.x
Pennells, 2019, Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies, Eur Heart J, 40, 621, 10.1093/eurheartj/ehy653
Pennells, 2014, Assessing risk prediction models using individual participant data from multiple studies, Am J Epidemiol, 179, 621, 10.1093/aje/kwt298
Otgontuya, 2013, Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia, BMC Public Health, 13, 539, 10.1186/1471-2458-13-539
Mendis, 2007, World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries, J Hypertens, 25, 1578, 10.1097/HJH.0b013e3282861fd3
Hajifathalian, 2015, A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys, Lancet Diabetes Endocrinol, 3, 339, 10.1016/S2213-8587(15)00081-9
Ridker, 2007, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score, JAMA, 297, 611, 10.1001/jama.297.6.611
Liu, 2004, Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study, JAMA, 291, 2591, 10.1001/jama.291.21.2591
Panagiotakos, 2007, Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project), Hellenic J Cardiol, 48, 55
Murray, 2017, Measuring global health: motivation and evolution of the Global Burden of Disease Study, Lancet, 390, 1460, 10.1016/S0140-6736(17)32367-X
Grey, 2018, First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005–2015, Heart, 104, 51, 10.1136/heartjnl-2017-311613
Goff, 2014, 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines, Circulation, 129, S49